U.K. to Force Listed Firms Disclose Pay Ratios Between CEOs & Workers in Corporate Governance Code Reform

U.K. to Force Listed Firms Disclose Pay Ratios Between CEOs & Workers in Corporate Governance Code Reform

The U.K. government is set to release further details of its corporate governance reforms Tuesday and expected to force listed companies to publish and justify pay ratios between top executives and their staff members, according to media reports. Following intense lobbying, the government is, however, expected to drop Prime Minister Theresa May’s plan to force firms to put employee representatives on boards, the media reports noted. Instead, companies will be […]

Read More ˃
BRF Names Lorival Nogueira Luz Jr. Chief Financial and Investor Relations Officer;

BRF Names Lorival Nogueira Luz Jr. Chief Financial and Investor Relations Officer;

BRF SA, a food producer, named Lorival Nogueira Luz Jr. as its new chief financial and investor relations officer effective from September. The hiring was approved by the board of directors, as per the recommendation of the global CEO. Luz has experience in different business sectors, such as, civil construction, energy, education and financing. His most recent position was at Votorantim Cimentos, where he acted as Finance and Investor Relations […]

Read More ˃
Cisco to Acquire Springpath

Cisco to Acquire Springpath

Cisco said Monday it plans to acquire Springpath, a Sunnyvale-based developer of hyperconvergence software for $320 million in cash and assumed equity awards, plus additional retention-based incentives. Springpath has developed a distributed file system purpose-built for hyperconvergence that enables server-based storage systems. Cisco said the acquisition will allow it to continue to deliver next-generation data center innovation to its customers. The companies have worked together since early 2016 to launch […]

Read More ˃
Tracon Pharmaceuticals Reports Positive Results from Trial of TRC105

Tracon Pharmaceuticals Reports Positive Results from Trial of TRC105

Tracon Pharmaceuticals has reported positive results from the National Cancer Institute (NCI) phase 1/2 trial of TRC105 and Nexavar (sorafenib) in hepatocellular cancer (HCC). NCI study researchers concluded that the combination of TRC105 and Nexavar was well-tolerated at the recommended single agent doses of both drugs, and that encouraging evidence of activity was observed. The data “suggest that the combination of TRC105 and Nexavar is active in patients with HCC […]

Read More ˃
Check Point Software Extends Share Buyback Program

Check Point Software Extends Share Buyback Program

Check Point Software Technologies, a network cyber security vendor globally, said early Friday that it has authorized an extension to its on-going share repurchase program. Under the updated plan, effective immediately, Check Point is authorized to continue to buy back up to $250 million of ordinary shares each quarter, up to $1 billion. From April 1, 2016 through June 30, 2017, Check Point bought back 14 million shares for an […]

Read More ˃
NovoCure Signs Contract With Austrian Insurers

NovoCure Signs Contract With Austrian Insurers

NovoCure said Tuesday it has signed a contract with the Federation of the Austrian Social Insurance Institutions, which grants reimbursement across Austria for Optune, Novocure’s Tumor Treating Fields delivery system, for the treatment of adults with newly diagnosed glioblastoma, a brain tumor. All 18 Austrian insurance funds have agreed to participate in the contract, the company said on Tuesday. Thus us Novocure’s first national reimbursement for Optune. The shares rose […]

Read More ˃